cvs caremark cigna - Search News

CVS, FTC and Cigna

FTC Slams UnitedHealth (NYSE:UNH), CVS and Cigna PBMs for Inflating Prices by $7.3B

The U.S. Federal Trade Commission (FTC) has slammed pharmacy benefit managers (PBMs) owned by UnitedHealth ($UNH), CVS Health ($CVS) and Cigna

YAHOO!Finance · 1d

FTC accuses CVS, Cigna, UnitedHealth of abusing middleman role, shares down

Cigna (NYSE:CI) Group, and UnitedHealth Group Inc (NYSE:UNH) were down around 1% after the Federal Trade Commission (FTC) accused their pharmacy benefit manager units of imposing significant price markups on specialty generic drugs,

Honolulu Star-Advertiser · 18h

FTC: Pharmacy benefit managers inflated drug prices by $7.3B

WASHINGTON >> The nation’s three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including for heart disease, cancer and HIV, at their affiliated pharmacies,

CNN on MSN · 1d

FTC finds middlemen inflate specialty generic drug prices by billions of dollars

Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty generic drugs between 2017 and 2022,

Quartz on MSN · 1d

CVS, Cigna, and UnitedHealth inflated cancer and HIV drug prices, FTC says

Three major drug middlemen needlessly marked up generic drugs for cancer, HIV, and multiple sclerosis to generate $7.3 billion in revenue, The Federal Trade Commission (FTC) said in a report released today.

19hon MSN

UnitedHealth, employer of slain exec Brian Thompson, found to have overcharged some cancer patients for drugs by over 1,000%

The report is the latest indictment of America’s broken healthcare system.

1don MSN

Top three insurers reaped $7.3 billion through their drug middlemen's markups, FTC says

Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...

Modern Healthcare1d

Big 3 PBMs reaped $7.3B from generic specialty drug markups: FTC

The Federal Trade Commission voted unanimously to release additional findings from its yearslong probe into CVS Caremark, ...

1don MSN

PBMs made billions marking up specialty drugs by more than 1,000 percent: FTC

The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...

Healthcare Dive1d

FTC releases second report slamming pharmacy benefit managers

Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...

Modern Healthcare10d

Where smaller PBMs are headed this year

Newer entrants to the pharmacy benefit management market will continue to face stiff competition in 2025 as they seek more ...

Hosted on MSN20h

FTC Report Reveals PBM Practices Impacting Competition and Drug Costs

The Federal Trade Commission (“FTC”) released its second interim report on Jan. 14, 2025, accusing pharmacy benefit managers (PBMs) of marking up the prices of specialty generic drugs. FTC’s report ...

Healthcare Dive7d

CVS successfully converts commercial pharmacy contracts to “cost plus” model

CVS’ efforts to reform how its pharmacies are paid have reached a significant milestone that should stabilize flagging ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results